# Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer

> **NCT02285192** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 42 (actual)

## Conditions studied

- Cervical Cancer
- Endometrial Cancer

## Interventions

- **RADIATION:** 18F-Fluorodeoxyglucose (18F-FDG)
- **DEVICE:** PET/CT imaging
- **DEVICE:** PET/MRI imaging

## Key facts

- **NCT ID:** NCT02285192
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-11
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02285192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02285192, "Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02285192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*